RET Inhibitors for RET-Altered Non-Small Cell Lung Cancer: Identification, Treatment, and Practicalities

Did you know that RET fusions have been detected in 1% to 2% of all lung cancers and can be treated with available targeted therapies? Credit available for this activity expires: 10/21/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/982531?src=mkm_podcast_addon_982531